Skip to main content
BioCentury on BioBusiness
Feature Story

Cover Story: Product Development: Takeda's patients

How Takeda is integrating the patient perspective into drug development

By Erin McCallister, Senior Editor

Takeda Pharmaceutical Co. Ltd. is trying to incorporate patient input throughout the drug development continuum, from early stage candidate selection to clinical trial design. While the pharma is hopeful that FDA will provide clarity on how it plans to integrate patient perspectives into drug reviews, Takeda isn't letting regulatory uncertainty slow down its efforts.

The pharma believes increased patient engagement will result in faster clinical trial recruitment and produce treatments that patients actually want and need.

Read Article

Today's Biotech & Pharma News

  • THE DISTILLERY brings you this week's most essential scientific findings in therapeutics, distilled by Innovations editors from a weekly review of more than 400 papers in 41 of the highest-impact journals in the fields of biotechnology, the life sciences and chemistry. The Distillery goes beyond the abstracts to explain the commercial relevance of featured research, including licensing status and companies working in the field, where applicable.

    This week in therapeutics includes important research findings on targets and compounds, grouped first by disease class and then alphabetically by indication.

    This week in techniques includes findings about research tools, disease models and manufacturing processes that have the potential to enable or improve all stages of drug discovery and development.

Subscribe Now
Free Trial